Filter News
Area of Research
- Advanced Manufacturing (1)
- Biology and Environment (24)
- Clean Energy (27)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (2)
- Energy Frontier Research Centers (1)
- Fusion and Fission (3)
- Isotopes (3)
- Materials (46)
- Materials for Computing (5)
- National Security (11)
- Neutron Science (44)
- Nuclear Science and Technology (3)
- Quantum information Science (1)
- Supercomputing (43)
News Type
News Topics
- (-) Biomedical (17)
- (-) Computer Science (61)
- (-) Environment (36)
- (-) Exascale Computing (10)
- (-) Nanotechnology (26)
- (-) Neutron Science (51)
- 3-D Printing/Advanced Manufacturing (45)
- Advanced Reactors (11)
- Artificial Intelligence (34)
- Big Data (7)
- Bioenergy (23)
- Biology (22)
- Biotechnology (8)
- Buildings (15)
- Chemical Sciences (32)
- Clean Water (2)
- Climate Change (22)
- Composites (11)
- Coronavirus (17)
- Critical Materials (11)
- Cybersecurity (17)
- Decarbonization (20)
- Education (3)
- Element Discovery (1)
- Energy Storage (43)
- Fossil Energy (1)
- Frontier (15)
- Fusion (17)
- Grid (16)
- High-Performance Computing (30)
- Isotopes (18)
- ITER (2)
- Machine Learning (13)
- Materials (59)
- Materials Science (53)
- Mercury (2)
- Microelectronics (1)
- Microscopy (16)
- Molten Salt (3)
- National Security (18)
- Net Zero (3)
- Nuclear Energy (27)
- Partnerships (29)
- Physics (24)
- Polymers (12)
- Quantum Computing (10)
- Quantum Science (27)
- Renewable Energy (1)
- Security (12)
- Simulation (9)
- Space Exploration (3)
- Statistics (1)
- Summit (21)
- Sustainable Energy (30)
- Transformational Challenge Reactor (4)
- Transportation (25)
Media Contacts
The Department of Energy’s Office of Science has allocated supercomputer access to a record-breaking 75 computational science projects for 2024 through its Innovative and Novel Computational Impact on Theory and Experiment, or INCITE, program. DOE is awarding 60% of the available time on the leadership-class supercomputers at DOE’s Argonne and Oak Ridge National Laboratories to accelerate discovery and innovation.
Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.
Using neutrons to see the additive manufacturing process at the atomic level, scientists have shown that they can measure strain in a material as it evolves and track how atoms move in response to stress.
ORNL has been selected to lead an Energy Earthshot Research Center, or EERC, focused on developing chemical processes that use sustainable methods instead of burning fossil fuels to radically reduce industrial greenhouse gas emissions to stem climate change and limit the crisis of a rapidly warming planet.
The Department of Energy’s Oak Ridge National Laboratory announced the establishment of the Center for AI Security Research, or CAISER, to address threats already present as governments and industries around the world adopt artificial intelligence and take advantage of the benefits it promises in data processing, operational efficiencies and decision-making.
The Spallation Neutron Source — already the world’s most powerful accelerator-based neutron source — will be on a planned hiatus through June 2024 as crews work to upgrade the facility. Much of the work — part of the facility’s Proton Power Upgrade project — will involve building a connector between the accelerator and the planned Second Target Station.
The Department of Energy’s Office of Science has selected three ORNL research teams to receive funding through DOE’s new Biopreparedness Research Virtual Environment initiative.
A new nanoscience study led by a researcher at ORNL takes a big-picture look at how scientists study materials at the smallest scales.
Technologies developed by researchers at ORNL have received six 2023 R&D 100 Awards.
After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at ORNL are now turning their drug design approach toward cancer.